FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/16/2026
Back to search
Official data from USPTO
TORBAY PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
TORBAY PHARMA
ST13
US500000079407751Class
5
Filing
79407751
Registration
8064008
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
07/16/2026
Trademark type
Word
Nice classes
5
Filing date
06/03/2024
Registration date
12/16/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/16/2025
Last transaction
07/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
MAHONEY, PAULA M
Law office
N10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Torbay Pharmaceuticals Limited
Representatives
Joseph V. Norvell Norvell IP llc
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for relief of painanaesthesiaacute hypotensionnutritional deficiencyeclampsiapre-eclampsia and ventricular failure; injectable pharmaceuticals for the treatment of relief of painanaesthesiaacute hypotensionnutritional deficiencyeclampsiapre-eclampsia and ventricular failure; drug delivery agents in the form of sterilized generic injectables that facilitate the delivery of pharmaceutical preparations.
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/28/2026
FIMP
FINAL DISPOSITION PROCESSED
06/28/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/09/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/23/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/23/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/16/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/16/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
12/16/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/28/2025
PUBO
PUBLISHED FOR OPPOSITION
10/28/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/22/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/28/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/08/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/07/2025
RFNT
REFUSAL PROCESSED BY IB
02/15/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/27/2025
RFRR
REFUSAL PROCESSED BY MPU
01/27/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/27/2024
CNRT
NON-FINAL ACTION WRITTEN
12/26/2024
DOCK
ASSIGNED TO EXAMINER
12/14/2024
MAFR
APPLICATION FILING RECEIPT MAILED
10/27/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/27/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/24/2024
Continuous trademark protection
Get notified about every new filing that threatens TORBAY PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.